Congratulations to Drs. Jordan Vellky and William Ricke on their new publication in Neoplasia! See the full manuscript here: https://www.sciencedirect.com/science/article/pii/S1476558620301482.
Ricke Lab
Dr. Debra Garvey received honorable mention for her abstract at the 2020 CAIRIBU meeting
Dr. Debra Garvey, postdoctoral researcher in Dr. Will Ricke’s lab, received honorable mention for her abstract at this year’s Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) meeting. Way to go, Dr. …
CAIRIBU Annual Meeting – Award Announcements
Dr. Teresa Liu (Assistant Scientist/K01 Scholar) and Livianna Myklebust (Research Assistant) tied for 1st place this year’s Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) meeting. Ricke Lab ‘close second’ awardees include: …
Ricke Lab Publication Image featured on American Journal of Pathology Cover
An image from a recent Ricke Lab publication (pubmed.ncbi.nlm.nih.gov/33039351/) was featured on January 2021 cover of the American Journal of Pathology!
Dr. Petra Popovics has been awarded a K01 Research Scientist Development Award!
A huge congratulations to Dr. Petra Popovics, co-mentored by Drs. Will Ricke and Chad Vezina, for being awarded a K01 Research Scientist Development Award to study “Osteopontin: A Novel Mediator of Prostatic Inflammation and Fibrosis”!
Dr. Lloyd and Dr. Ricke discuss the impact of BPH/LUTS from a global perspective
Recent work from Bryn Launer (University of Colorado), Dr. Kevin McVary (Loyola University Medical Center), Dr. Will Ricke (UW-Madison O’Brien Center), and Dr. Granville Lloyd (University of Colorado) demonstrates the global impact of BPH/LUTS. Learn more: https://bjui-journals.onlinelibrary.wiley.com/doi/abs/10.1111/bju.15286
Ricke lab describes the role of nucleolar protein BOP1 in advanced prostate disease
New research from the Ricke lab and PhD candidate Jordan Vellky describes the implication of the nucleolar protein BOP1 in advanced prostate disease. Nucleolar protein BOP1 has been associated with multiple malignancies, but it has …